SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-096669
Filing Date
2024-08-14
Accepted
2024-08-14 08:07:08
Documents
70
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q vrca-20240630.htm   iXBRL 10-Q 1506087
2 EX-4.1 vrca-ex4_1.htm EX-4.1 135748
3 EX-10.1 vrca-ex10_1.htm EX-10.1 60055
4 EX-10.2 vrca-ex10_2.htm EX-10.2 66476
5 EX-10.3 vrca-ex10_3.htm EX-10.3 66197
6 EX-10.4 vrca-ex10_4.htm EX-10.4 71593
7 EX-31.1 vrca-ex31_1.htm EX-31.1 13870
8 EX-31.2 vrca-ex31_2.htm EX-31.2 14112
9 EX-32.1 vrca-ex32_1.htm EX-32.1 11717
  Complete submission text file 0000950170-24-096669.txt   7260507

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT vrca-20240630.xsd EX-101.SCH 1219542
73 EXTRACTED XBRL INSTANCE DOCUMENT vrca-20240630_htm.xml XML 939451
Mailing Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380
Business Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380 484-453-3300
Verrica Pharmaceuticals Inc. (Filer) CIK: 0001660334 (see all company filings)

IRS No.: 463137900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38529 | Film No.: 241204275
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)